Chemed Corp. vs Quest Diagnostics
Chemed Corp. (CHE) and Quest Diagnostics (DGX) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $7.14B
- Last close
- $548.59
- 12 months
- +27.8%
- Market value
- $28.4B
- Last close
- $258.28
- 12 months
- +37.7%
At a glance
- The biggest part of Chemed Corp.'s revenue is VITAS, 64% of the total in its last annual report.
- By market value, Quest Diagnostics ($28.4B) is about 4.0 times Chemed Corp. ($7.1B).
- Over the last 12 months Chemed Corp.'s share price moved +27.8% and Quest Diagnostics's +37.7%; against the S&P 500 that is +22.1 points and +32.0 points.
- In their last fiscal years Chemed Corp. kept 10.5% of revenue as net income and Quest Diagnostics 9.0%.
- In the last 90 days insiders reported 0 open-market purchases at Chemed Corp. and 0 at Quest Diagnostics; members of Congress disclosed 0 trades in Chemed Corp. and 0 in Quest Diagnostics.
- Next results: Chemed Corp. Feb 23, 2027, Quest Diagnostics Feb 8, 2027.
How each one makes money: Chemed Corp. revenue · Quest Diagnostics revenue
Share prices on one chart
Chemed Corp. and Quest Diagnostics, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Chemed Corp. CHENYSE · Health Care Services | Quest Diagnostics DGXNYSE · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $7.14B | $28.4B |
| Revenue, last fiscal year | $2.53B | $11B |
| Net income, last fiscal year | $265M | $992M |
| Net marginNet income as a share of revenue | 10.5% | 9.0% |
| Free cash flow | $325M | $1.36B |
| Net debt | ||
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Quest Diagnostics against
Common questions
How is Chemed Corp. different from Quest Diagnostics?
Chemed Corp. (CHE) is in Health Care Services on NYSE, with $2.53B of revenue in its last fiscal year and a net margin of 10.5%. Quest Diagnostics (DGX) is in Health Care Services on NYSE, with $11B of revenue in its last fiscal year and a net margin of 9.0%. The biggest part of Chemed Corp.'s revenue is VITAS, 64% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Chemed Corp. and Quest Diagnostics compare in size?
Quest Diagnostics has the larger market value: Chemed Corp. $7.14B and Quest Diagnostics $28.4B, at the last close.
Whose share price rose more over the last 12 months, CHE or DGX?
Over the last 12 months Chemed Corp. moved +27.8% and Quest Diagnostics +37.7%. Past price moves say nothing about the future.
Which has had more insider buying, Chemed Corp. or Quest Diagnostics?
Since 2006, Chemed Corp. insiders reported 53 open-market purchases against 8 for Quest Diagnostics. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CHE or DGX?
In the last 12 months, members of Congress disclosed 0 trades in Chemed Corp. (CHE) and 8 in Quest Diagnostics (DGX).
When did insiders last buy CHE and DGX?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Chemed Corp. pageQuest Diagnostics pageRare insider trades this weekAll comparisons
https://oqro.io/compare/che-vs-dgx



